Myeloid cells in cancer-related inflammation

Immunobiology

Volumn 220, Issue 2, 2015, Pages 249-253

  Caronni, Nicoletta ^a,b   Savino, Benedetta ^a,b   Bonecchi, Raffaella ^a,b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Cancer related inflammation; Chemokine; Myeloid cells; Myeloid derived suppressor cells; Tumor associated macrophages; Tumor associated neutrophils

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR;

ARTICLE; BONE MARROW; BONE MARROW CELL; CANCER GROWTH; CANCER RELATED INFLAMMATION; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MOTILITY; CELL POLARITY; CYTOKINE RELEASE; HUMAN; IMMUNE DEFICIENCY; INFLAMMATION; LYMPHOID ORGAN; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR IMMUNITY; TUMOR INVASION; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; VASCULAR REMODELING; ANIMAL; CELL MOTION; IMMUNOLOGY; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; BONE MARROW; CELL MOVEMENT; HUMANS; INFLAMMATION; MYELOID CELLS; NEOPLASM METASTASIS; NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 84926419753     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.10.001     Document Type: Article

References (82)

1. Bharadwaj U., et al. Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation. Cancer Res. 2007, 67(11):5479-5488.
2. Bottazzi B., et al. Regulation of the macrophage content of neoplasms by chemoattractants. Science 1983, 220(4593):210-212.
3. Chiba S., et al. Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat. Immunol. 2012, 13(9):832-842.
4. Cortez-Retamozo V., et al. Origins of tumor-associated macrophages and neutrophils. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(7):2491-2496.
5. Curry J.M., et al. M-CSF signals through the MAPK/ERK pathway via Sp1 to induce VEGF production and induces angiogenesis in vivo. PLoS ONE 2008, 3(10):e3405.
6. DeNardo D.G., et al. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009, 16(2):91-102.
7. Deng J., et al. S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. Cancer Cell 2012, 21(5):642-654.
8. Duyndam M.C., et al. Vascular endothelial growth factor-165 overexpression stimulates angiogenesis and induces cyst formation and macrophage infiltration in human ovarian cancer xenografts. Am. J. Pathol. 2002, 160(2):537-548.
9. Elinav E., et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat. Rev. Cancer 2013, 13(11):759-771.
10. Engelhardt J.J., et al. Marginating dendritic cells of the tumor microenvironment cross-present tumor antigens and stably engage tumor-specific T cells. Cancer Cell 2012, 21(3):402-417.
11. Erler J.T., et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 2009, 15(1):35-44.
12. Eruslanov E., et al. Pivotal advance: tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE catabolism in myeloid cells. J. Leukoc. Biol. 2010, 88(5):839-848.
13. Fend L., et al. Therapeutic effects of anti-CD115 monoclonal antibody in mouse cancer models through dual inhibition of tumor-associated macrophages and osteoclasts. PLOS ONE 2013, 8(9):e73310.
14. Feng A.L., et al. CD16+ monocytes in breast cancer patients: expanded by monocyte chemoattractant protein-1 and may be useful for early diagnosis. Clin. Exp. Immunol. 2011, 164(1):57-65.
15. Fridlender Z.G., et al. Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils. PLoS ONE 2012, 7(2):e31524.
16. Gabrilovich D.I., Ostrand-Rosenberg S., Bronte V. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 2012, 12(4):253-268.
17. Gao D., et al. Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition. Cancer Res. 2012, 72(6):1384-1394.
18. Garg A.D., Dudek A.M., Agostinis P. Cancer immunogenicity, danger signals, and DAMPs: what, when, and how?. Biofactors 2013, 39(4):355-367.
19. Ginhoux F., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330(6005):841-845.
20. Granot Z., et al. Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell 2011, 20(3):300-314.
21. Graves D.T., et al. Expression of monocyte chemotactic protein-1 in human melanoma in vivo. Am. J. Pathol. 1992, 140(1):9-14.
22. Guilliams M., et al. Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J. Exp. Med. 2013, 210(10):1977-1992.
23. Hamilton M.J., et al. Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomas. J. Immunol. 2014, 192(1):512-522.
24. Hargadon K.M. Tumor-altered dendritic cell function: implications for anti-tumor immunity. Front. Immunol. 2013, 4:192.
25. Hiratsuka S., et al. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(16):9349-9354.
26. Hiratsuka S., et al. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2002, 2(4):289-300.
27. Hiratsuka S., et al. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 2006, 8(12):1369-1375.
28. Hiratsuka S., et al. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat. Cell Biol. 2008, 10(11):1349-1355.
29. Hume D.A., MacDonald K.P. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood 2012, 119(8):1810-1820.
30. Jamieson T., et al. Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J. Clin. Investig. 2012, 122(9):3127-3144.
31. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 2009, 9(4):239-252.
32. Kaplan R.N., et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005, 438(7069):820-827.
33. Kim S., et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 2009, 457(7225):102-106.
34. Kowanetz M., et al. Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(50):21248-21255.
35. Krysko D.V., et al. Immunogenic cell death and DAMPs in cancer therapy. Nat. Rev. Cancer 2012, 12(12):860-875.
36. Kubota Y., et al. M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis. J. Exp. Med. 2009, 206(5):1089-1102.
37. Lamouille S., Xu J., Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 2014, 15(3):178-196.
38. Leek R.D., et al. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J. Pathol. 2000, 190(4):430-436.
39. Leung S.Y., et al. Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas. Acta Neuropathol. 1997, 93(5):518-527.
40. Li C., et al. Knockdown of VEGF receptor-1 (VEGFR-1) impairs macrophage infiltration: angiogenesis and growth of clear cell renal cell carcinoma (CRCC). Cancer Biol. Ther. 2011, 12(10):872-880.
41. Lin E.Y., Pollard J.W. Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res. 2007, 67(11):5064-5066.
42. Lu Y., et al. Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion. Prostate 2006, 66(12):1311-1318.
43. Ma Y., et al. Dendritic cells in the cancer microenvironment. J. Cancer 2013, 4(1):36-44.
44. Maeda H., et al. TGF-beta enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice. J. Immunol. 1995, 155(10):4926-4932.
45. Mantovani A., et al. Cancer-related inflammation. Nature 2008, 454(7203):436-444.
46. Markiewski M.M., et al. Modulation of the antitumor immune response by complement. Nat. Immunol. 2008, 9(11):1225-1235.
47. Martin A.P., et al. Increased expression of CCL2 in insulin-producing cells of transgenic mice promotes mobilization of myeloid cells from the bone marrow: marked insulitis, and diabetes. Diabetes 2008, 57(11):3025-3033.
48. Mauti L.A., et al. Myeloid-derived suppressor cells are implicated in regulating permissiveness for tumor metastasis during mouse gestation. J. Clin. Investig. 2011, 121(7):2794-2807.
49. Mishalian I., et al. Neutrophils recruit regulatory T-cells into tumors via secretion of CCL17-a new mechanism of impaired antitumor immunity. Int. J. Cancer 2014, 135(5):1178-1186.
50. Murray P.J., et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 2014, 41(1):14-20.
51. Negus R.P., et al. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J. Clin. Investig. 1995, 95(5):2391-2396.
52. Nowicki A., et al. Impaired tumor growth in colony-stimulating factor 1 (CSF-1)-deficient, macrophage-deficient op/op mouse: evidence for a role of CSF-1-dependent macrophages in formation of tumor stroma. Int. J. Cancer 1996, 65(1):112-119.
53. Oh K., et al. A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model. Breast Cancer Res. 2013, 15(5):R79.
54. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 2004, 4(1):71-78.
55. Priceman S.J., et al. Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy. Blood 2010, 115(7):1461-1471.
56. Qian B.Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141(1):39-51.
57. Qian B.Z., et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 2011, 475(7355):222-225.
58. Riethdorf L., et al. Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri. Am. J. Pathol. 1996, 149(5):1469-1476.
59. Roca H., et al. CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization. J. Biol. Chem. 2009, 284(49):34342-34354.
60. Sanford D.E., et al. Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis. Clin. Cancer Res. 2013, 19(13):3404-3415.
61. Savino B., et al. ERK-dependent downregulation of the atypical chemokine receptor D6 drives tumor aggressiveness in Kaposi sarcoma. Cancer Immunol. Res. 2014, 2(7):679-689.
62. Sawanobori Y., et al. Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. Blood 2008, 111(12):5457-5466.
63. Schmid M.C., et al. Combined blockade of integrin-alpha4beta1 plus cytokines SDF-1alpha or IL-1beta potently inhibits tumor inflammation and growth. Cancer Res. 2011, 71(22):6965-6975.
64. Schmidt H., et al. Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br. J. Cancer 2005, 93(3):273-278.
65. Schulz C., et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012, 336(6077):86-90.
66. Shi C., Pamer E.G. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 2011, 11(11):762-774.
67. Shi C., et al. Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands. Immunity 2011, 34(4):590-601.
68. Sinha P., Clements V.K., Ostrand-Rosenberg S. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis. Cancer Res. 2005, 65(24):11743-11751.
69. Sionov R.V., Fridlender Z.G., Granot Z. The multifaceted roles neutrophils play in the tumor microenvironment. Cancer Microenviron. 2014.
70. Solinas G., et al. Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility. J. Immunol. 2010, 185(1):642-652.
71. Soria G., Ben-Baruch A. The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett. 2008, 267(2):271-285.
72. Swirski F.K., et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009, 325(5940):612-616.
73. Tacke F., et al. Monocyte subsets differentially employ CCR2: CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Investig. 2007, 117(1):185-194.
74. Tiemessen M.M., et al. CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(49):19446-19451.
75. Torroella-Kouri M., et al. Identification of a subpopulation of macrophages in mammary tumor-bearing mice that are neither M1 nor M2 and are less differentiated. Cancer Res. 2009, 69(11):4800-4809.
76. Tsou C.L., et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Investig. 2007, 117(4):902-909.
77. Van Overmeire E., et al. Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues. Front. Immunol. 2014, 5:127.
78. Wong S.C., et al. Macrophage polarization to a unique phenotype driven by B cells. Eur. J. Immunol. 2010, 40(8):2296-2307.
79. Yan H.H., et al. Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung. Cancer Res. 2010, 70(15):6139-6149.
80. Yang L., et al. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 2008, 13(1):23-35.
81. Youn J.I., Gabrilovich D.I. The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur. J. Immunol. 2010, 40(11):2969-2975.
82. Zhou S.L., et al. CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils. Carcinogenesis 2014, 35(3):597-605.